BGC
PFE icon

Blue Granite Capital’s Pfizer PFE Stock Holding History

Blue Granite Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$658K Sell
19,204
-36,169
-65% -$1.23M 0.48% 28
2017
Q3 		$1.88M Sell
55,373
-70,264
-56% -$2.26M 1.3% 26
2017
Q2 		$4M Buy
125,637
+685
+0.5% +$21.6K 2.59% 4
2017
Q1 		$4.06M Buy
124,952
+8,432
+7% +$266K 2.65% 5
2016
Q4 		$3.59M Buy
+116,520
New +$3.56M 2.55% 5

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Granite Capital's PFE Position: Q4 2017 in Review

Blue Granite Capital reduced its Pfizer (PFE) stake by 65% in Q4 2017, selling an estimated $1.23M and leaving 19,204 shares worth $658K. The position accounts for 0.48% of the portfolio, ranked #28.

Blue Granite Capital first reported a position in PFE in Q4 2016 and has held it in 5 quarters since. The position peaked at $4.06M in Q1 2017. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Blue Granite Capital held 19,204 shares of Pfizer worth $658K as of Q4 2017.
  • Blue Granite Capital sold 36,169 Pfizer shares in Q4 2017, an estimated $1.23M.
  • Pfizer made up 0.48% of Blue Granite Capital's portfolio in Q4 2017, its #28 holding.
  • Blue Granite Capital first reported a position in Pfizer in Q4 2016 and has held it in 5 quarters since.
  • Blue Granite Capital's Pfizer position peaked at $4.06M in Q1 2017.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Blue Granite Capital's 13F filing for Q4 2017, filed 14 Feb 2018.